BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Black Hawk Acquisition Corp
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026
$4.03−1.98 (-32.95%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Black Hawk Acquisition Corp balance sheet
Ratios
Latest available, balances at Aug 31, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -44.2%
Financial strength
- Current ratio
- 0.02
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –